U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of the Commissioner
  5. Office of the Chief Scientist
  6. National Center for Toxicological Research
  7. Science & Research (NCTR)
  8. FDA Grand Rounds – NCTR Presentations
  1. Science & Research (NCTR)

FDA Grand Rounds – NCTR Presentations

FDA Grand Rounds by NCTR scientists. Each 45-minute session presents a key public health challenge and how FDA is applying science to its regulatory activities.

NCTR Grand Rounds Presentations

FDA Grand Rounds (with images representing science at FDA: food and medical products, scientist in lab, and microscopic virus image)

2024

Salmonella and Escherichia coli: Challenges Along the One Health Continuum
Presented by Steven Foley, Ph.D., Director, Division of Microbiology

Evaluating Mutagenicity by Error-Corrected Sequencing
Presented by Javier Revollo, Ph.D., Research Biologist, Division of Genetic and Molecular Toxicology

2023

The Plasmid Puzzle—Finding Solutions in Salmonella
Presented by Kristina Feye, M.S., Ph.D., Research Biologist, Division of Microbiology, 

Electron Microscopy—Still a Powerful Research Tool
Presented by Angel Paredes, Ph.D., Director of Electron Microscopy, Office of Scientific Coordination 

Microphysiological Systems as Novel Disease Models and Drug Development Tools
Presented by Dayton Petibone, Ph.D., Research Biologist, Division of Genetic and Molecular Toxicology, and Qiang Shi, Ph.D., Visiting Scientist, Division of Systems Biology

2022

An Overview of Tattoo Ink Research at the National Center for Toxicological Research
Presented by Peter Kim, Ph.D., Staff Fellow, Division of Microbiology

2021

Studies of SARS-CoV-2 NSP1 and Envelope Protein
Presented by Marli Azevedo, Ph.D., Research Biologist, Division of Microbiology

2020

Nanotechnology: Over a Decade of Progress and Innovation at FDA
Presented by Anil Patri, Ph.D., Chair, Nanotechnology Task Force, Director, Nanocore

Artificial Intelligence for Regulatory Science Research
Presented by Weida Tong, Ph.D., Director of Division of Bioinformatics and Biostatistics

2019

Overview of FDA’s Perinatal Health Center of Excellence: Development and Validation of Predictive Systems
Presented by Amy Inselman, Ph.D., Division of Systems Biology, Biomarkers and Alternative Models Branch

2018

Bisphenol A: Toxicology and Pharmacokenetic Data to Inform Ongoing Safety Assessments
Presented by Barry Delclos, Ph.D., Research Pharmacologist, Division of Biochemical Toxicology

Ethnicity- and Gender-Related Differences in Alzheimer’s Disease
Presented by Sherry Ferguson, Ph.D., Research Psychologist, Division of Neurotoxicology, and Vijayalakshmi Varma, Ph.D., Research Biologist

Resources for You

Subscribe to NCTR Research Highlights Newsletter

Get regular FDA email updates delivered on this topic to your inbox.

Back to Top